70 Participants NeededMy employer runs this trial
Gene Therapy for Multiple Myeloma
(inMMyCAR Trial)
Recruiting at 6 trial locations
SC
Overseen BySVP Clinical Development
Age: 18+
Sex: Any
Trial Phase: Phase 1
Sponsor: Kelonia Therapeutics, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
What You Need to Know Before You Apply
What is the purpose of this trial?
The goal of this clinical trial is to evaluate the safety, tolerability, and recommended Phase 2 Dose (RP2D) of KLN-1010 in patients with relapsed or refractory multiple myeloma.
Are You a Good Fit for This Trial?
Inclusion Criteria
My multiple myeloma has returned after treatment and is measurable.
I've had 3 types of treatments for my condition, including PI, IMiD, and a CD38 antibody.
I am fully active or can carry out light work.
See 1 more
What Are the Treatments Tested in This Trial?
Interventions
- KLN-1010
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Group I: KLN-1010Experimental Treatment1 Intervention
Drug: KLN-1010 specified dose given once
Find a Clinic Near You
Who Is Running the Clinical Trial?
Kelonia Therapeutics, Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.